156
Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir.
 an HIV type 1-infected patient: Subject; Iatrogenic Cushing syndrome: Effect; receiving therapy with ritonavir-lopinavir: Treatment; epidural triamcinolone injections: Treatment; HIV type 1: Treatment.Disorder; epidural triamcinolone: Treatment.Drug; ritonavir-lopinavir: Treatment.Drug; injections: Treatment.Route; epidural triamcinolone: Combination.Drug; ritonavir-lopinavir: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 an HIV type 1-infected patient: Subject; Iatrogenic Cushing syndrome: Effect; receiving therapy with ritonavir-lopinavir: Treatment; epidural triamcinolone injections: Treatment; HIV type 1: Treatment.Disorder; epidural triamcinolone: Treatment.Drug; ritonavir-lopinavir: Treatment.Drug; injections: Treatment.Route; epidural triamcinolone: Combination.Drug; ritonavir-lopinavir: Combination.Drug